share_log

复星医药(02196.HK)4月29日举行董事会会议考虑及通过一季度业绩

Fosun Pharmaceutical (02196.HK) held a board meeting on April 29 to consider and approve the first quarter results

Gelonghui Finance ·  Apr 17 04:50

Gelonghui, April 17, 丨 Fosun Pharmaceutical (02196.HK) announced that it will hold a board meeting on April 29, 2024 (Monday) to consider, approve and publish the first quarter results of the company and its subsidiaries for the three months ended March 31, 2024.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment